Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb 27;24(5):4596.
doi: 10.3390/ijms24054596.

Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies

Affiliations
Editorial

Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies

Antonietta Bernardo et al. Int J Mol Sci. .

Abstract

Demyelinating diseases are a group of pathologies characterized by the alteration of myelin-that is, the coating that wraps around most of the nerve fibres of the central and peripheral nervous system, whose goal is the improvement of nerve conduction and the preservation of energy spent during action potential propagation [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Special Issue “Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies”. [(accessed on 1 January 2020)];Int. J. Mol. Sci. Available online: https://www.mdpi.com/journal/ijms/special_issues/demyelinating_diseases. - PMC - PubMed
    1. Balestri S., Del Giovane A., Sposato C., Ferrarelli M., Ragnini-Wilson A. The Current Challenges for Drug Discovery in CNS Remyelination. Int. J. Mol. Sci. 2021;22:2891. doi: 10.3390/ijms22062891. - DOI - PMC - PubMed
    1. Kim B.S. Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler’s Virus-Induced Demyelinating Disease. Int. J. Mol. Sci. 2021;22:5254. doi: 10.3390/ijms22105254. - DOI - PMC - PubMed
    1. Khodanovich M.Y., Kamaeva D.A., Naumova A.V. Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19. Int. J. Mol. Sci. 2022;23:11291. doi: 10.3390/ijms231911291. - DOI - PMC - PubMed
    1. Guerriero C., Puliatti G., Di Marino T., Tata A.M. Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis. Int. J. Mol. Sci. 2022;23:3615. doi: 10.3390/ijms23073615. - DOI - PMC - PubMed

Publication types